USPTO serial 79356514
CHIRAL CQ QUEST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 28, 2024
- Examiner
- RIEPEL, CHRISTINA MAXINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CHIRAL CQ QUEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Hydrochlorates; benzene derivatives being industrial chemicals; p-aminophenol; agricultural chemicals, except fungicides, herbicides, insecticides and parasiticides; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; catalysts for oxidation process; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; catalysts for chemical and biochemical processes | ACTIVE | — |
| 005 | Medicines for human purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemico-pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; drugs for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; biological preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; amino acids for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; active pharmaceutical ingredient, namely amino acids derivatives, chiral or heterocyclic molecular derivatives for medical purposes; chemical reagents for medical or veterinary purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for pharmaceutical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology | ACTIVE | — |
| 040 | Recycling of chemicals; water treating; cryopreservation services; medicinal materials processing, namely processing of amino acids derivatives, chiral or heterocyclic molecular derivatives; chemical processing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Chiral Quest (Suzhou) Co., Ltd.
- Other trademarks owned by Chiral Quest (Suzhou) Co., Ltd.
- Other trademarks owned by Chiral Quest (Suzhou) Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Similar marks named CHIRAL CQ QUEST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 10, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 10, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 28, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 28, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 29, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 29, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 29, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 29, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 3, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |